Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Why we need pre-exposure prophylaxis: incident HIV and syphilis among men, and transgender women, who have sex with men, Bangkok, Thailand, 2005-2015.

Holtz TH, Wimonsate W, Mock PA, Pattanasin S, Chonwattana W, Thienkrua W, Sukwicha W, Curlin ME, Chitwarakorn A, Dunne EF.

Int J STD AIDS. 2019 Apr;30(5):430-439. doi: 10.1177/0956462418814994. Epub 2019 Jan 9.

2.

The first year of the global Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in Bangkok, Thailand, 2015-2016.

Sirivongrangson P, Girdthep N, Sukwicha W, Buasakul P, Tongtoyai J, Weston E, Papp J, Wi T, Cherdtrakulkiat T, Dunne EF; EGASP Thailand Workgroup.

PLoS One. 2018 Nov 9;13(11):e0206419. doi: 10.1371/journal.pone.0206419. eCollection 2018.

3.

Selling and buying sex in the city: men who have sex with men in the Bangkok men who have sex with men Cohort Study.

Dunne EF, Pattanasin S, Chemnasiri T, Varangrat A, Raengsakulrach B, Wichuda S, Ungsedhapand C, Sirivongrangson P, Chitwarakorn A, Holtz TH.

Int J STD AIDS. 2019 Mar;30(3):212-222. doi: 10.1177/0956462418796440. Epub 2018 Oct 26.

PMID:
30360682
4.

Repeat HIV testing among HIV-uninfected men who have sex with men attending Silom Community Clinic, Bangkok, 2011 - 2014.

Wimonsate W, Pattanasin S, Ungsedhapand C, Pancharoen K, Luechai P, Satumay K, Winaitham S, Sukwicha W, Sirivongrangsan P, Dunne EF, Holtz TH.

Int J STD AIDS. 2018 Aug 16:956462418788724. doi: 10.1177/0956462418788724. [Epub ahead of print]

PMID:
30115000
5.

Screening for Chlamydia trachomatis and Neisseria gonorrhoeae infection among asymptomatic men who have sex with men in Bangkok, Thailand.

Pattanasin S, Dunne EF, Wasinrapee P, Tongtoyai J, Chonwattana W, Sriporn A, Luechai P, Mock PA, Chitwarakorn A, Holtz TH, Curlin ME.

Int J STD AIDS. 2018 May;29(6):577-587. doi: 10.1177/0956462417744904. Epub 2017 Dec 4.

6.

Young Men Who Have Sex with Men at High Risk for HIV, Bangkok MSM Cohort Study, Thailand 2006-2014.

Thienkrua W, van Griensven F, Mock PA, Dunne EF, Raengsakulrach B, Wimonsate W, Howteerakul N, Ungsedhapand C, Chiwarakorn A, Holtz TH.

AIDS Behav. 2018 Jul;22(7):2137-2146. doi: 10.1007/s10461-017-1963-7.

7.

More testing, more questions: Screening tests for oral human papillomavirus infection.

Sullivan-Chang L, Saraiya M, Dunne EF, Brooks JT.

J Am Dent Assoc. 2017 Nov;148(11):781-783. doi: 10.1016/j.adaj.2017.08.023. No abstract available.

8.

Monitoring the impact of HPV vaccine in males-Considerations and challenges.

Brotherton JML, Giuliano AR, Markowitz LE, Dunne EF, Ogilvie GS.

Papillomavirus Res. 2016 Dec;2:106-111. doi: 10.1016/j.pvr.2016.05.001. Epub 2016 May 17.

9.

Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.

Pathela P, Jamison K, Papadouka V, Kabir R, Markowitz LE, Dunne EF, Schillinger JA.

J Adolesc Health. 2016 Dec;59(6):710-715. doi: 10.1016/j.jadohealth.2016.07.021. Epub 2016 Sep 23.

PMID:
27671357
10.

Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.

McNicholl JM, Leelawiwat W, Whitehead S, Hanson DL, Evans-Strickfaden T, Cheng CY, Chonwattana W, Mueanpai F, Kittinunvorakoon C, Markowitz L, Dunne EF.

Int J STD AIDS. 2017 Mar;28(4):372-379. doi: 10.1177/0956462416650123. Epub 2016 Jul 10.

11.

Prevalence of HPV After Introduction of the Vaccination Program in the United States.

Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER.

Pediatrics. 2016 Mar;137(3):e20151968. doi: 10.1542/peds.2015-1968. Epub 2016 Feb 22.

12.

Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.

Park IU, Introcaso C, Dunne EF.

Clin Infect Dis. 2015 Dec 15;61 Suppl 8:S849-55. doi: 10.1093/cid/civ813. Review.

PMID:
26602622
13.

HPV Vaccination Coverage of Male Adolescents in the United States.

Lu PJ, Yankey D, Jeyarajah J, O'Halloran A, Elam-Evans LD, Smith PJ, Stokley S, Singleton JA, Dunne EF.

Pediatrics. 2015 Nov;136(5):839-49. doi: 10.1542/peds.2015-1631.

14.

Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012-2013.

Dunne EF, Naleway A, Smith N, Crane B, Weinmann S, Braxton J, Steinau M, Unger ER, Markowitz LE.

J Infect Dis. 2015 Dec 15;212(12):1970-5. doi: 10.1093/infdis/jiv342. Epub 2015 Jun 29.

PMID:
26123561
15.

Human papillomavirus vaccination of females in a large health claims database in the United States, 2006-2012.

Dunne EF, Stokley S, Chen W, Zhou F.

J Adolesc Health. 2015 Apr;56(4):408-13. doi: 10.1016/j.jadohealth.2015.01.004.

16.

Antibody responses among adolescent females receiving the quadrivalent HPV vaccine series corresponding to standard or non-standard dosing intervals.

Russell K, Dunne EF, Kemper AR, Dolor RJ, Unger ER, Panicker G, Markowitz LE, Walter EB.

Vaccine. 2015 Apr 15;33(16):1953-8. doi: 10.1016/j.vaccine.2015.02.058. Epub 2015 Mar 3.

PMID:
25744229
17.

Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003-2010.

Petrosky EY, Hariri S, Markowitz LE, Panicker G, Unger ER, Dunne EF.

Int J Infect Dis. 2015 Apr;33:137-41. doi: 10.1016/j.ijid.2015.01.010. Epub 2015 Jan 14.

18.

The estimated lifetime probability of acquiring human papillomavirus in the United States.

Chesson HW, Dunne EF, Hariri S, Markowitz LE.

Sex Transm Dis. 2014 Nov;41(11):660-4. doi: 10.1097/OLQ.0000000000000193.

19.

The estimated impact of human papillomavirus vaccine coverage on the lifetime cervical cancer burden among girls currently aged 12 years and younger in the United States.

Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.

Sex Transm Dis. 2014 Nov;41(11):656-9. doi: 10.1097/OLQ.0000000000000199.

20.

National human papillomavirus vaccination coverage among adolescents aged 13-17 years-National Immunization Survey--teen, United States, 2011.

Curtis CR, Dorell C, Yankey D, Jeyarajah J, Chesson H, Saraiya M, Gold R, Dunne EF, Stokley S; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2014 Sep 12;63(2):61-70. No abstract available.

PMID:
25208260
21.

Pain in adolescent girls receiving human papillomavirus vaccine with concomitantly administered vaccines.

Walter EB, Kemper AR, Dolor RJ, Dunne EF.

Pediatr Infect Dis J. 2015 Feb;34(2):200-2. doi: 10.1097/INF.0000000000000537.

PMID:
25170553
22.

Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr, Unger ER; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2014 Aug 29;63(RR-05):1-30. Erratum in: MMWR Recomm Rep. 2014 Dec 12;63(49):1182.

23.

Preparing for human papillomavirus vaccine introduction in Kenya: implications from focus-group and interview discussions with caregivers and opinion leaders in Western Kenya.

Friedman AL, Oruko KO, Habel MA, Ford J, Kinsey J, Odhiambo F, Phillips-Howard PA, Wang SA, Collins T, Laserson KF, Dunne EF.

BMC Public Health. 2014 Aug 16;14:855. doi: 10.1186/1471-2458-14-855.

24.

Human papilloma virions in the laboratory.

Dunne EF, Markowitz LE, Taylor LD, Unger ER, Wheeler CM.

J Clin Virol. 2014 Oct;61(2):196-8. doi: 10.1016/j.jcv.2014.06.014. Epub 2014 Jun 23. Review.

25.

Evaluation of a surveillance case definition for anogenital warts, Kaiser Permanente northwest.

Naleway AL, Weinmann S, Crane B, Gee J, Markowitz LE, Dunne EF.

Sex Transm Dis. 2014 Aug;41(8):496-500. doi: 10.1097/OLQ.0000000000000154.

PMID:
25013978
26.

Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the U.S.A., National Health and Nutrition Examination Surveys, 2003-2006.

Introcaso CE, Dunne EF, Hariri S, Panicker G, Unger ER, Markowitz LE.

Sex Transm Infect. 2014 Sep;90(6):505-8. doi: 10.1136/sextrans-2013-051490. Epub 2014 Apr 19.

PMID:
24748563
27.

CDC grand rounds: Reducing the burden of HPV-associated cancer and disease.

Dunne EF, Markowitz LE, Saraiya M, Stokley S, Middleman A, Unger ER, Williams A, Iskander J; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Jan 31;63(4):69-72.

28.

Systematic review of human papillomavirus vaccine coadministration.

Noronha AS, Markowitz LE, Dunne EF.

Vaccine. 2014 May 13;32(23):2670-4. doi: 10.1016/j.vaccine.2013.12.037. Epub 2014 Jan 8. Review.

PMID:
24412351
29.

Reply to Groner et al and Pei et al.

Markowitz LE, Hariri S, Dunne EF, Steinau M, Unger ER.

J Infect Dis. 2014 Apr 15;209(8):1304-5. doi: 10.1093/infdis/jit835. Epub 2013 Dec 23. No abstract available.

PMID:
24368839
30.

Would young women attending sexually transmitted disease clinics benefit from human papillomavirus vaccination? An assessment of human papillomavirus DNA and seropositivity from human papillomavirus sentinel surveillance, 2003-2005.

Dunne EF, Flagg EW, Unger ER, Hsu K, Ghanen K, Kerndt P, Shlay JC, Koutsky LA, Datta DS, Panicker G, Zaidi A, Weinstock H, Markowitz LE.

Sex Transm Dis. 2014 Jan;41(1):46-9. doi: 10.1097/OLQ.0000000000000071.

PMID:
24326582
31.

Prevalence of cervical and oral human papillomavirus infections among US women.

Steinau M, Hariri S, Gillison ML, Broutian TR, Dunne EF, Tong ZY, Markowitz LE, Unger ER.

J Infect Dis. 2014 Jun 1;209(11):1739-43. doi: 10.1093/infdis/jit799. Epub 2013 Dec 5.

32.

HPV and HPV-associated diseases.

Dunne EF, Park IU.

Infect Dis Clin North Am. 2013 Dec;27(4):765-78. doi: 10.1016/j.idc.2013.09.001. Review.

PMID:
24275269
33.

Population impact of HPV vaccines: summary of early evidence.

Hariri S, Markowitz LE, Dunne EF, Unger ER.

J Adolesc Health. 2013 Dec;53(6):679-82. doi: 10.1016/j.jadohealth.2013.09.018. Review.

PMID:
24263069
34.

HPV vaccination of boys in primary care practices.

Allison MA, Dunne EF, Markowitz LE, O'Leary ST, Crane LA, Hurley LP, Stokley S, Babbel CI, Brtnikova M, Beaty BL, Kempe A.

Acad Pediatr. 2013 Sep-Oct;13(5):466-74. doi: 10.1016/j.acap.2013.03.006.

35.

HPV genotypes detected in cervical cancers from Alaska Native women, 1980-2007.

Kelly JJ, Unger ER, Dunne EF, Murphy NJ, Tiesinga J, Koller KR, Swango-Wilson A, Philemonof D, Lounmala X, Markowitz LE, Steinau M, Hennessy T.

Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.21115. eCollection 2013.

36.

Incidence of genital warts in adolescents and young adults in an integrated health care delivery system in the United States before human papillomavirus vaccine recommendations.

Camenga DR, Dunne EF, Desai MM, Gee J, Markowitz LE, Desiliva A, Klein NP.

Sex Transm Dis. 2013 Jul;40(7):534-8. doi: 10.1097/OLQ.0b013e3182953ce0.

PMID:
23965766
37.

Evaluation of genital self-sampling methods for HPV detection in males.

Hernandez BY, Wilkens LR, Unger ER, Steinau M, Markowitz L, Garvin K, Thompson PJ, Shvetsov YB, O'Dillon K, Dunne EF.

J Clin Virol. 2013 Sep;58(1):168-75. doi: 10.1016/j.jcv.2013.06.032. Epub 2013 Jul 20.

PMID:
23880161
38.

Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.

Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.

Vaccine. 2013 Aug 20;31(37):3899-905. doi: 10.1016/j.vaccine.2013.06.050. Epub 2013 Jun 29.

39.

Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.

Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, Unger ER.

J Infect Dis. 2013 Aug 1;208(3):385-93. doi: 10.1093/infdis/jit192. Epub 2013 Jun 19.

PMID:
23785124
40.

Cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ: comparison of ICD-9 codes and pathology results--Kaiser Permanente, United States, 2000-2005.

Surie D, Dunne EF, Naleway AL, Weinmann S, Klein NP, Baxter R, Hutchins K, Gee J, Markowitz L.

Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1129-32. doi: 10.1158/1055-9965.EPI-12-1413. Epub 2013 Apr 5.

41.

Human papillomavirus vaccine initiation and awareness: U.S. young men in the 2010 National Health Interview Survey.

Lu PJ, Williams WW, Li J, Dorell C, Yankey D, Kepka D, Dunne EF.

Am J Prev Med. 2013 Apr;44(4):330-338. doi: 10.1016/j.amepre.2012.11.027.

42.

Cyclic changes in HIV shedding from the female genital tract during the menstrual cycle.

Curlin ME, Leelawiwat W, Dunne EF, Chonwattana W, Mock PA, Mueanpai F, Thep-Amnuay S, Whitehead SJ, McNicholl JM.

J Infect Dis. 2013 May 15;207(10):1616-20. doi: 10.1093/infdis/jit063. Epub 2013 Feb 15.

PMID:
23417658
43.

Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, Su J, Xu F, Weinstock H.

Sex Transm Dis. 2013 Mar;40(3):187-93. doi: 10.1097/OLQ.0b013e318286bb53. Review.

PMID:
23403598
44.

Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact.

Dunne EF, Klein NP, Naleway AL, Baxter R, Weinmann S, Riedlinger K, Fetterman B, Steinau M, Scarbrough MZ, Gee J, Markowitz LE, Unger ER.

Cancer Causes Control. 2013 Feb;24(2):403-7. doi: 10.1007/s10552-012-0085-9. Epub 2013 Jan 5.

PMID:
23292130
46.

HIV-1 and herpes simplex virus type-2 genital shedding among co-infected women using self-collected swabs in Chiang Rai, Thailand.

Forhan SE, Dunne EF, Sternberg MR, Whitehead SJ, Leelawiwat W, Thepamnuay S, Chen C, Evans-Strickfaden T, McNicholl JM, Markowitz LE.

Int J STD AIDS. 2012 Aug;23(8):560-4. doi: 10.1258/ijsa.2012.011295.

PMID:
22930292
47.

HPV vaccine implementation in STD clinics--STD Surveillance Network.

Meites E, Llata E, Hariri S, Zenilman J, Longfellow L, Schwebke J, Tabidze I, Mettenbrink C, Jenkins H, Guerry S, Pathela P, Asbel L, Stover JA, Bernstein K, Kerani RP, Dunne EF, Markowitz LE.

Sex Transm Dis. 2012 Jan;39(1):32-4. doi: 10.1097/OLQ.0b013e3182315584.

PMID:
22183843
48.

Updates on human papillomavirus and genital warts and counseling messages from the 2010 Sexually Transmitted Diseases Treatment Guidelines.

Dunne EF, Friedman A, Datta SD, Markowitz LE, Workowski KA.

Clin Infect Dis. 2011 Dec;53 Suppl 3:S143-52. doi: 10.1093/cid/cir703.

PMID:
22080267
49.

Chlamydia partner services for females in California family planning clinics.

Yu YY, Frasure-Williams JA, Dunne EF, Bolan G, Markowitz L, Bauer HM.

Sex Transm Dis. 2011 Oct;38(10):913-8. doi: 10.1097/OLQ.0b013e3182240366.

PMID:
21934563
50.

The cost-effectiveness of male HPV vaccination in the United States.

Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.

Vaccine. 2011 Oct 26;29(46):8443-50. doi: 10.1016/j.vaccine.2011.07.096. Epub 2011 Aug 2.

PMID:
21816193

Supplemental Content

Loading ...
Support Center